Evidence map›Paper›PMID 27814964›Full record

ReviewLancet (London, England)2017

Changing global policy to deliver safe, equitable, and affordable care for women's cancers.

Ophira Ginsburg, Rajan Badwe, Peter Boyle, Gemma Derricks, Anna Dare, Tim Evans, Alexandru Eniu, Jorge Jimenez, Tezer Kutluk, Gilberto Lopes and 10 more

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03324009 (Development of a Two-stage Cervical Cancer Screening Algorithm for Botswana), which is not on this map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03324009 nacompletednot on this mapstarted 2018, after this paper: background citation

Development of a Two-stage Cervical Cancer Screening Algorithm for Botswana

TypeinterventionalSponsorBeth Israel Deaconess Medical CenterRan2018 to 2020Enrolled239ConditionsCervical Cancer, HIV/AIDSArms2-stage screen
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Access to brachytherapy treatment for cervical cancer management in Africa.Clinical and translational radiation oncology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Ophira GinsburgWomen's College Research Institute, Faculty of Medicine, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; World Health Organization, Geneva, Switzerland. Electronic address: ophira.ginsburg@wchospital.ca.
Rajan BadweTata Memorial Centre, Mumbai, India.
Peter BoyleInternational Prevention Research Institute, Lyon, France; University of Strathclyde Institute of Global Public Health @iPRI, Glasgow, UK.
Gemma DerricksBrunel University, London, UK.
Anna DareCentre for Global Health Research & Department of Surgery, University of Toronto, Toronto, ON, Canada.
Tim EvansHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Alexandru EniuCancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
Jorge JimenezPontificia Universidad, Católica de Chile, Santiago, Chile.
Tezer KutlukDepartment of Pediatric Oncology, Hacettepe University, Ankara, Turkey.
Gilberto LopesOncoclinicas Group, São Paulo, Brazil; University of Miami, Miller School of Medicine, Coral Gables, FL, USA.
Sulma I MohammedPurdue Center for Cancer Research, Purdue University, West Lafayette, IN, USA; Indiana University School of Medicine, Indianapolis, IN, USA.
You-Lin QiaoDepartment of Cancer Epidemiology, National Cancer Centre, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China.
Sabina Faiz RashidJames P Grant School of Public Health at BRAC University, Dhaka, Bangladesh.
Diane SummersUNICEF, South Asia Regional Office, Kathmandu, Nepal.
Diana SarfatiDepartment of Public Health, University of Otago, Wellington, New Zealand.
Marleen TemmermanWorld Health Organization, Geneva, Switzerland; Ghent University, Ghent, Belgium; Aga Khan University, East Africa, Nairobi, Kenya.
Edward L TrimbleNCI Centre for Global Health, Bethesda, MD, USA.
Aasim I PadelaInitiative on Islam and Medicine and Department of Medicine, University of Chicago, Chicago, IL, USA.
Ajay AggarwalLondon School of Hygiene & Tropical Medicine, London, UK; Institute of Cancer Policy, Kings Health Partners Comprehensive Cancer Centre, King's Centre for Global Health, King's Health Partners and King's College London, UK.
Richard SullivanInstitute of Cancer Policy, Kings Health Partners Comprehensive Cancer Centre, King's Centre for Global Health, King's Health Partners and King's College London, UK.

Funding

Department of Health DRF-2014-07-064World Health Organization 001
6 · The paper itself

Abstract

Breast and cervical cancer are major threats to the health of women globally, particularly in low-income and middle-income countries. Radical progress to close the global cancer divide for women requires not only evidence-based policy making, but also broad multisectoral collaboration that capitalises on recent progress in the associated domains of women's health and innovative public health approaches to cancer care and control. Such multisectoral collaboration can serve to build health systems for cancer, and more broadly for primary care, surgery, and pathology. This Series paper explores the global health and public policy landscapes that intersect with women's health and global cancer control, with new approaches to bringing policy to action. Cancer is a major global social and political priority, and women's cancers are not only a tractable socioeconomic policy target in themselves, but also an important Trojan horse to drive improved cancer control and care.

Indexed as

Developing CountriesWomen's HealthFemaleGlobal HealthHumansPolicy MakingPublic PolicySocioeconomic FactorsWomen's Rights

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.